Protein Dynamic Solutions LLC

Enabling better Protein Therapeutics

Meet our team at these Upcoming Events

2018 Workshop on Protein Aggregation and Immunogenicity

July 30 - Aug 02, Breckenridge CO

Recognized as the preeminent meeting of thought leaders in protein aggregation ad immunogenicity, this conference brings together leaders from the biologics industry and regulatory agencies

Event website:

10th Annual Bioprocessing Summit - see us at oral presentation, poster and booth #604

Aug 13 - 17, Boston, MA

A gathering of more than 1,000 international bioprocess professionals to share practical solutions for today's bioprocess challenges.

Oral Presentation: Monday Aug 13 at 4:15 pm by Dr. Belinda Pastrana 

"High-Throughput Critical Quality Attribute testing for enhancing speed to market & minimizing risk."

Event website:

SciX 2018 - a meeting of the Federation of Analytical Chemistry and Spectroscopy Societies (FACSS)

Oct 20 -26, Atlanta, GA

SciX covers all areas of analytical chemistry. The 2018 conference includes focus sessions on Bioanalysis and Vibrational Spectroscopy.

Oral Presentation by Dr. Belinda Pastrana

"Comparability Assessment of Several Recombinant Proteins and Synthetic Peptides using 2D IR and Co-distribution Correlation Spectroscopies” 

Event website:

PDS in the News

Protein Dynamic Solutions Named to “The Most Valuable Venture-Backed Startups in All 50 States”


Wakefield, MA – July 16, 2018 – Protein Dynamic Solutions LLC (PDS), developer of breakthrough technologies for structural characterization of therapeutic proteins, was recognized by Business Insider for provision of instruments and contract research services to the biopharmaceutical industry.

The listing was researched and compiled by PitchBook and represented in their infographic on the most valuable VC-backed company in each US state.

Read the entire release here:

Protein Dynamic Solutions establishes new headquarters and operations in Massachusetts

Wakefield, MA – June 16, 2018 – Protein Dynamic Solutions LLC (PDS), developer of platforms for biopharmaceutical critical quality attribute (CQA) and biosimilar assessment, has recently established a new head office, as well as research and operations, in Wakefield, Massachusetts.

Founded in Puerto Rico by veterans of the biopharmaceutical industry, PDS is a provider of tools for high-throughput developability and comparability (HT-DCA) testing of therapeutic proteins. Their novel, array-based platforms incorporate bench-top laser microscopes and novel high-throughput sample handling and analysis technologies to provide visual and hyper-spectral analyses of biotherapeutics; thus, informing the structures, mechanisms and amino acid residues involved in protein stability, aggregation and change.

“We are very excited to establish a presence in the Boston biotechnology hub,” said Belinda Pastrana, Founder and CEO. “We have worked in, and supported, global biopharma companies for many years and it’s invigorating to now have a home at the source of many of the innovations in our industry. We are delighted to be geographically co-located with our key clients and partners and to play an intimate role in their go-forward pipeline strategies.”

Read the entire release here:

PDS' CEO delivers presentation at 2018 PITTCON William Wright Award

February 2018

Dr. Belinda Pastrana, the CEO of Protein Dynamic Solutions, was invited as a speaker at the The Coblentz Society - Williams Wright Award at this year's PITTCON meeting, recognizing and honoring scientists who have made outstanding contributions to analytical chemistry and applied spectroscopy.

About the award:

Protein Dynamic Solutions LLC is awarded a NSF SBIR Phase II TECP Supplemental award

August 2017

PDS was awarded a continuation of a previously funded SBIR Phase II Award with grant of additional TECP supplemental funding in support of Proof of Concept analysis in partnership with Catalent Biologics.

About Catalent Biologics:

Protein Dynamic Solutions LLC is awarded a NSF SBIR Phase II Award

September 2016

Continuing in its strong history for awarding of industry grants, PDS was awarded the SBIR Phase II Award.

Award Details:

Protein Dynamic Solutions LLC is selected to participate in NIH I-Corps workshop

March 2016

PDS was honored to be one of four companies selected for the NIH I-Corps workshop - a program that seeks to develop and nurture a national innovation ecosystem that builds upon biomedical research to develop technologies, products, and services that benefit society.

As a participant, PDS leaders received instruction and mentoring from industry experts in order to accelerate the translation of its breakthrough technologies. Scientific rigor, societal impact and business models were reviewed and vetted by over 185 professionals from the biopharmaceutical industry and government regulatory authorities.

Read about the program and interview with PDS' CEO Belinda Pastrana:

Protein Dynamic Solutions LLC is accepted into the Life Sciences Entrepreneurs Acceleration Program

December 2015

The law firm of McDermott, Will and Emery welcomed Protein Dynamic Solutions, LLC into its prestigious Life Sciences Entrepreneurs Acceleration Program (LEAP).

The program works with entrepreneurs to provide sophisticated advice on a broad range of legal and business issues and accelerate the progression of companies to meet strategic objectives.

Candidates for LEAP are sponsored by a McDermott partner and evaluated on the quality of their business plan, the ability of the company to meet well-defined milestones, current levels of investment (or the likelihood of obtaining venture-backed financing), and clearance of a business and legal conflict evaluation.

Program overview:

Protein Dynamic Solutions LLC is awarded a NSF SBIR Phase I Award

January 2015

Protein Dynamic Solutions LLC is awarded a NSF SBIR Phase I Award

Award Details:

Protein Dynamic Solutions awarded Puerto Rico Science & Technology Trust Collaborative Agreement

January 2013